- Home
- PRIM vs RYTM Comparison
PRIM vs RYTM Comparison
Compare PRIM & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRIM
- RYTM
- Stock Information
- Founded
- PRIM 1960
- RYTM 2008
- Country
- PRIM United States
- RYTM United States
- Employees
- PRIM N/A
- RYTM N/A
- Industry
- PRIM Water Sewer Pipeline Comm & Power Line Construction
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- PRIM Industrials
- RYTM Health Care
- Exchange
- PRIM Nasdaq
- RYTM Nasdaq
- Market Cap
- PRIM 6.6B
- RYTM 6.4B
- IPO Year
- PRIM N/A
- RYTM 2017
- Fundamental
- Price
- PRIM $137.71
- RYTM $100.52
- Analyst Decision
- PRIM Strong Buy
- RYTM Strong Buy
- Analyst Count
- PRIM 12
- RYTM 13
- Target Price
- PRIM $119.17
- RYTM $109.77
- AVG Volume (30 Days)
- PRIM 840.4K
- RYTM 612.9K
- Earning Date
- PRIM 11-03-2025
- RYTM 11-04-2025
- Dividend Yield
- PRIM 0.23%
- RYTM N/A
- EPS Growth
- PRIM 55.06
- RYTM N/A
- EPS
- PRIM 4.40
- RYTM N/A
- Revenue
- PRIM $6,929,274,000.00
- RYTM $156,287,000.00
- Revenue This Year
- PRIM $13.48
- RYTM $46.10
- Revenue Next Year
- PRIM $9.16
- RYTM $60.39
- P/E Ratio
- PRIM $31.68
- RYTM N/A
- Revenue Growth
- PRIM 15.08
- RYTM 53.55
- 52 Week Low
- PRIM $49.10
- RYTM $45.91
- 52 Week High
- PRIM $141.54
- RYTM $106.52
- Technical
- Relative Strength Index (RSI)
- PRIM 64.55
- RYTM 55.79
- Support Level
- PRIM $135.00
- RYTM $96.30
- Resistance Level
- PRIM $141.54
- RYTM $102.79
- Average True Range (ATR)
- PRIM 4.28
- RYTM 3.08
- MACD
- PRIM -0.26
- RYTM 0.00
- Stochastic Oscillator
- PRIM 70.64
- RYTM 70.23
About PRIM Primoris Services Corporation
Primoris Services Corp is a provider of infrastructure services operating mainly in the United States and Canada. It provides a wide range of construction services, maintenance, replacement, fabrication and engineering services to a diversified base of customers. The reportable segments are the Utilities segment and the Energy segment. The Utilities segment operates in a range of services, including the installation and maintenance of new and existing natural gas and electric utility distribution and transmission systems, and communication systems. The Energy segment operates in a range of services that include engineering, procurement, and construction, retrofits, highway and bridge construction, demolition, site work, outages, pipeline construction and maintenance, and others.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.